NVO

NOVO NORDISK A S

Pharmaceuticals · Pharmaceuticals

$273.41 sample

-3.07 (-1.11%) 1D

Market cap

$296.2B

Price as of

2026-10-15

Latest filing

8-K · 2026-09-23

Alerts

8

Price$273.41 -2.48% 3M daily closessample

293.71270.50

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 12INSInsider sell: Director
Oct 07INSInsider buy: Director
Oct 02INSInsider buy: Director
Sep 23SECForm 144 filed
Sep 14INSInsider buy: Chief Executive Officer
Sep 04INSInsider sell: Chief Financial Officer
Aug 31INSInsider sell: General Counsel
Aug 21INSInsider buy: Chief Executive Officer

Sign up to see the real NVO record →

Company facts

SEC EDGAR registration

Name: NOVO NORDISK A S
Sector: Pharmaceuticals
Industry: Pharmaceuticals
Smart-money score: +16sample, -100 to +100
Reporting currency: USD

Who is positioning in NVO

sample

Insiders: 25 insider transactions over 90 days, net selling, $740.5M
Congress: No member trades over 90 days
Institutions · 13F: 33 funds hold $3.3B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$15.1B +11.9% y/y

Q4 2024Q3 2026

Inventory$9.2B +11.2% y/y

Q4 2024Q3 2026

Accounts receivable$6.8B +7.4% y/y

Q4 2024Q3 2026

Total debt$17.4B +9.9% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $40.7B +1.9% 3M
Sample peer B: $109.4B +11.9% 3M
Sample peer C: $230.2B +7.9% 3M
Sample peer D: $121.1B +15.0% 3M
Sample peer E: $295.7B -9.9% 3M